Search Results
Nov 23, 2025, 02:35 ET Ho Chi Minh Ville s'associe à Vietnam Airlines pour promouvoir le tourisme vietnamien en Europe du Nord - Lancement de vols directs entre Ho Chi Minh Ville et Copenhague (Danemark)
nautiques et les loisirs haut de gamme, qui enrichit le portefeuille touristique de la ville et élargit l'expérience des visiteurs.Mme Bui Thi Ngoc Hieu, directrice adjointe du département du tourisme de Ho Chi Minh-Ville, a souligné que le lancement du vol direct vers Copenhague revêtait
More news about: Ho Chi Minh City Department of Tourism
Nov 22, 2025, 23:41 ET Ho Chi Minh City partners with Vietnam Airlines to promote Vietnamese tourism in Northern Europe - Launching direct flights between Ho Chi Minh City and Copenhagen (Denmark)
for beach tourism, water sports, and high-end leisure, enriching the city's tourism portfolio and expanding the visitor experience.Ms. Bui Thi Ngoc Hieu, Deputy Director of the Ho Chi Minh City Department of Tourism, emphasized that the launch of the direct flight to Copenhagen holds special
More news about: Ho Chi Minh City Department of Tourism
Nov 21, 2025, 04:02 ET ViewSonic Unveils Global Winners of the 6th ColorPro Awards: FLOW
Parallel Flow Melts into Breath" by Bui Xuan Viet of Vietnam unites the frozen stillness of ice and the living pulse of the sea. The work symbolizes the eternal flow that bridges silence and
More news about: ViewSonic
Nov 21, 2025, 04:02 ET ViewSonic Unveils Global Winners of the 6th ColorPro Awards: FLOW
Parallel Flow Melts into Breath" by Bui Xuan Viet of Vietnam unites the frozen stillness of ice and the living pulse of the sea. The work symbolizes the eternal flow that bridges silence and
More news about: ViewSonic
Nov 18, 2025, 08:50 ET Halozyme Completes Acquisition of Elektrofi, Expanding Breadth of Offerings in Drug Delivery
statements or any other information contained herein. Contacts Tram BuiHalozymeVP, Investor Relations and Corporate Communications609-359-3016
More news about: Halozyme Therapeutics, Inc.
Nov 17, 2025, 07:00 ET Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab
Corporate Communications 617-230-4165 [email protected] Tram BuiHalozymeVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Nov 07, 2025, 08:30 ET FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma
reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Nov 06, 2025, 23:37 ET Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
is also the site of its operations facility. Contacts Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Nov 05, 2025, 16:05 ET Halozyme Therapeutics, Inc. Announces Proposed Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
is also the site of its operations facility. Contacts Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Nov 04, 2025, 10:00 ET Over 230,000 Boaters Contacted During the 2025 Operation Dry Water Weekend
During the three-day weekend, 451 law enforcement agencies deployed 7,311 officers, resulting in 501 boating under the influence (BUI) arrests nationwide. Officers contacted 232,694 boaters aboard 87,830 vessels, issuing 25,968 safety warnings and 8,577 citations for various violations.
More news about: Operation Dry Water
Nov 03, 2025, 16:01 ET HALOZYME RAISES 2025 FINANCIAL GUIDANCE AND REPORTS STRONG THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS
forward-looking statements to reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Oct 21, 2025, 08:30 ET Halozyme to Report Third Quarter 2025 Financial and Operating Results
and connect with us on LinkedIn and Twitter. Contacts: Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Oct 01, 2025, 07:00 ET Halozyme to Acquire Elektrofi, Expanding Our Offerings in Innovative Drug Delivery and Strengthening Long-Term Growth into 2040s
statements or any other information contained herein. Contact Tram BuiHalozymeVP, Investor Relations and Corporate Communications609-359-3016
More news about: Halozyme Therapeutics, Inc.
Sep 19, 2025, 08:37 ET Chung-Ang University Researchers Reveal MoBluRF: A Framework for Creating Sharp 4D Reconstructions from Blurry Videos
Professor Munchurl Kim from Korea Advanced Institute of Science and Technology (KAIST), Korea, along with Mr. Minh-Quan Viet Bui, and Mr. Jongmin Park, developed MoBluRF, a two-stage motion deblurring method for NeRFs. "Our framework can reconstruct
More news about: Chung-Ang University
Sep 12, 2025, 08:59 ET Level Up Your Dog's Snack Game with Beggin' Blocks and "A Minecraft Movie"
Boyter, Jason Momoa, Jill Messick, Torfi Frans Olafsson and Vu Bui producing, and Todd Hallowell, Kayleen Walters, Brian Mendoza,
More news about: Purina
Aug 28, 2025, 08:30 ET Halozyme to Participate at Upcoming Investor Conferences
Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, and Tram Bui, VP of Investor Relations and Corporate Communications, are scheduled to participate and host investor meetings at the following investor conferences.
More news about: Halozyme Therapeutics, Inc.
Aug 05, 2025, 16:01 ET HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG SECOND QUARTER 2025 RESULTS
Company undertakes no duty to update forward-looking statements to reflect events after the date of this release. Contacts:Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Jul 23, 2025, 11:36 ET European Commission Approved DARZALEX Faspro® for Adult Patients with Smouldering Multiple Myeloma
Halozyme undertakes no duty to update forward-looking statements to reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Jul 22, 2025, 08:30 ET Halozyme to Report Second Quarter 2025 Financial and Operating Results
www.halozyme.com and connect with us on LinkedIn and Twitter. Contacts: Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Jul 08, 2025, 04:41 ET Study tour bolsters Sino-Vietnamese youth exchanges
said. In addition to historical education, the program showcased Guizhou's rural development and innovation. Bui Kim Dung, 26, was captivated by the beautiful scenery of Huamao Village in Zunyi. "Even the rural areas here are astonishing, with new houses
More news about: China Daily
Jul 03, 2025, 12:08 ET AZ Blue Donates $80K to Support U of A Health Student Training
Olivia Chavez Vy Bui Kimberly Pierson
More news about: Blue Cross Blue Shield of Arizona
Jun 30, 2025, 16:05 ET Halozyme Therapeutics Added to Russell 1000® Index
Halozyme undertakes no duty to update forward-looking statements to reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Jun 20, 2025, 13:15 ET Halozyme Announces argenx Received European Commission Approval for VYVGART® Subcutaneous Injection with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Halozyme undertakes no duty to update forward-looking statements to reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate [email protected]
More news about: Halozyme Therapeutics, Inc.
Jun 11, 2025, 07:00 ET DOLLARAMA REPORTS FISCAL 2026 FIRST QUARTER RESULTS
sales relative to the same period in the prior fiscal year. For further information: Investors: Patrick Bui, Chief Financial Officer, (514) 737-1006 x1237, [email protected]: Lyla Radmanovich, PELICAN PR, (514) 845-8763, [email protected]
More news about: Dollarama Inc.